Both these two complexes, independently of each other, use the lipid soluble carrier located into the IMM, ubiquinone (coenzyme Q) to form ubiquinol
Subcutaneous Drug Injection Review (PMC) Pharmacologic considerations of the subcutaneous route for drug delivery
Its pharmacology is relatively narrow: it stimulates lipolysis through beta-3 adrenergic receptor pathways in adipose tissue and may inhibit lipogenesis [1]
This combination leads to a more significant and sustained weight loss compared to using either treatment alone
VDR activation in osteoblasts promotes the synthesis of extracellular matrix proteins, such as type I collagen, osteopontin, and osteocalcin, and increases the expression of osteogenic markers including Runx2, Osx, and ALP (142)